.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
."this should not have happened and should never be allowed to happen again to another vulnerable person or their family.
.
https://grassfed.us/Staser-neighbour-of-Burlile-from-Barcem
'indian ip and liabilities law barrier to pharma r&d investment'
.